Reduced purine biosynthesis in humans after their divergence from Neandertals
Stepanova VPapers in this archive, Moczulska KEPapers in this archive, Vacano GNPapers in this archive, Kurochkin IPapers in this archive, Ju XPapers in this archive, Riesenberg SPapers in this archive, Macak DPapers in this archive, Maricic TPapers in this archive, Dombrowski LPapers in this archive, Schörnig MPapers in this archive, Anastassiadis KPapers in this archive, Baker OPapers in this archive, Naumann RPapers in this archive, Khrameeva EPapers in this archive, Vanushkina APapers in this archive, Stekolshchikova EPapers in this archive, Egorova APapers in this archive, Tkachev APapers in this archive, Mazzarino RPapers in this archive, Duval NPapers in this archive, Zubkov DPapers in this archive, Giavalisco PPapers in this archive, Wilkinson TGPapers in this archive, Patterson DPapers in this archive, Khaitovich PPapers in this archive, Pääbo SPapers in this archive
Abstract
We analyze the metabolomes of humans, chimpanzees, and macaques in muscle, kidney and three different regions of the brain. Although several compounds in amino acid metabolism occur at either higher or lower concentrations in humans than in the other primates, metabolites downstream of adenylosuccinate lyase, which catalyzes two reactions in purine synthesis, occur at lower concentrations in humans. This enzyme carries an amino acid substitution that is present in all humans today but absent in Neandertals. By introducing the modern human substitution into the genomes of mice, as well as the ancestral, Neandertal-like substitution into the genomes of human cells, we show that this amino acid substitution contributes to much or all of the reduction of de novo synthesis of purines in humans.
This page indexes the study's public bibliographic record. The full text belongs to the journal; follow the DOI above to read it at the source.